Vergis, Maxiber B.

HRN: 24-39-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2024
CEFTRIAXONE 1G (VIAL)
02/04/2024
02/10/2024
IVT
2g
Q24
UTI
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes